ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A03FA01 | G | Metoclopramide - 10mg/2ml | 9733 | 186844/1 | VOMICARE INJECTION BP IM/IV | 10mg/2ml | 10 x 2ml | Injectable solution | IV/IM | Drugstore 3U S.A.R.L. | Swiss Parenterals Ltd | India | 247,267 L.L | 23.08 | A1 | Swiss Parenterals Ltd | India | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A03FA01 | G | Metoclopramide HCl - 10mg/2ml | 2793 | E0344/91 | CHLORHYDRATE DE METOCLOPRAMIDE RENAUDIN | 10mg/2ml | 10 x 2ml | Injectable solution | IV/IM | Minapharm Halabi | Renaudin | France | 530,818 L.L | 23.08 | A1 | Renaudin | 2/5/2024 | 0 | |
A03FA01 | G | Metoclopramide HCl - 10mg/2ml | 8871 | 167315/1 | ELITAN | 10mg/2ml | 10 | Injectable solution | IV/IM | New Allpharma | Medochemie Ltd | Cyprus | 252,642 L.L | 23.08 | A1 | Medochemie Ltd | Cyprus | 2/5/2024 | 0 |
A03FA01 | G | Metoclopramide HCl - 10mg/2ml | 9605 | 90318/1 | METOCLOPRAMIDE S.A.L.F. | 10mg/2ml | 5 x 2ml | Injectable solution | IV/IM | New Europharm | SALFSpA Laboratorio Farmacologico | Italy | 255,330 L.L | 23.08 | A1 | SALFSpA Laboratorio Farmacologico | Italy | 2/5/2024 | 0 |
A03FA01 | G | Metoclopramide HCl - 10mg/2ml | 7713 | 48014/1 | METORAM | 10mg/2ml | 5 | Injectable solution | IV/IM | Raymond Georges Abou Adal & Co | Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 421,071 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
A03FA01 | G | Metoclopramide HCl - 10mg/2ml | 9087 | 63217/1 | METORAM | 10mg/2ml | 50 | Injectable solution | IV/IM | Raymond Georges Abou Adal & Co | Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 3,026,845 L.L | 23.08 | B | 2/5/2024 | 0 |